Daljit Singh Aurora
Corporate Officer/Principal at NEUMORA THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Daljit Singh Aurora is currently the Chief Development Officer at Neumora Therapeutics, Inc. He previously held positions as the VP-Worldwide Compliance & Business Ethics at Amgen, Inc. from 2013 to 2014, Vice President at Neurocrine Biosciences, Inc. from 2015 to 2016, Vice President at Merck Research Laboratories Massachusetts LLC from 2014 to 2015, and Chief Scientific Affairs Officer at Dermira, Inc. from 2019 to 2021.
He obtained his undergraduate degree from The University of Texas at Austin and his doctorate degree from The University of Texas Health Science Center at Houston.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-21 | 212,203 ( 0.13% ) | 3 M $ | 2024-03-30 |
Daljit Singh Aurora active positions
| Companies | Position | Start |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-07-31 |
Former positions of Daljit Singh Aurora
| Companies | Position | End |
|---|---|---|
| DERMIRA, INC. | Compliance Officer | 2019-10-31 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 2016-06-30 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 2015-03-31 |
| AMGEN INC. | Corporate Officer/Principal | 2014-08-31 |
Training of Daljit Singh Aurora
| The University of Texas at Austin | Undergraduate Degree |
| The University of Texas Health Science Center at Houston | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- Daljit Singh Aurora
